Skip to main content

Articles

Page 11 of 15

  1. Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater empha...

    Authors: Mandy Maredza, Lumbwe Chola and Karen Hofman
    Citation: Cost Effectiveness and Resource Allocation 2016 14:2
  2. Despite improvements in a number of health outcome indicators partly due to the National Health Insurance Scheme (NHIS), Ghana is unlikely to attain all its health-related millennium development goals before t...

    Authors: Robert Kaba Alhassan, Edward Nketiah-Amponsah, James Akazili, Nicole Spieker, Daniel Kojo Arhinful and Tobias F Rinke de Wit
    Citation: Cost Effectiveness and Resource Allocation 2015 13:23
  3. The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific economic model based on a chronic obstructive pulmona...

    Authors: Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila and Martin O’Leary
    Citation: Cost Effectiveness and Resource Allocation 2015 13:22
  4. All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimburs...

    Authors: Guvenc Kockaya, Akin Kose, Fatma Betul Yenilmez, Oktay Ozdemir and Ece Kucuksayrac
    Citation: Cost Effectiveness and Resource Allocation 2015 13:21
  5. The rapid and continuous growth of health care cost aggravates the frequently low priority and less attention given in financing laboratory services. The poorest countries have the highest out-of-pocket spend...

    Authors: Kasaw Adane, Zenegnaw Abiy and Kassu Desta
    Citation: Cost Effectiveness and Resource Allocation 2015 13:20
  6. In the Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST elevation myocardial infarction (FAMOUS) clinical trial, FFR was shown to significantly reduce coro...

    Authors: Julian Nam, Andrew Briggs, Jamie Layland, Keith G. Oldroyd, Nick Curzen, Arvind Sood, Kanarath Balachandran, Raj Das, Shahid Junejo, Hany Eteiba, Mark C. Petrie, Mitchell Lindsay, Stuart Watkins, Simon Corbett, Brian O’Rourke, Anna O’Donnell…
    Citation: Cost Effectiveness and Resource Allocation 2015 13:19
  7. Sequential treatment of ankylosing spondylitis (AS) that includes tumour necrosis factor-α antagonists (anti-TNF agents) has been applied in most of the Western countries. Existing cost-effectiveness (CE) mode...

    Authors: An Tran-Duy, Annelies Boonen, Mart A. F. J. van de Laar and Johan L. Severens
    Citation: Cost Effectiveness and Resource Allocation 2015 13:18
  8. In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of ...

    Authors: Jennifer M. Poonsapaya, Michael Einodshofer, Heather S. Kirkham, Pheophilus Glover and Janeen DuChane
    Citation: Cost Effectiveness and Resource Allocation 2015 13:17
  9. Prepaid contributory systems are increasingly being recognized as key mechanisms in achieving universal health coverage in low and middle-income countries. Peru created the Seguro Integral de Salud (SIS) to in...

    Authors: Daniel Cobos Muñoz, Kristian Schultz Hansen, Fern Terris-Prestholt, Fiona Cianci, José Enrique Pérez-Lu, Aldo Lama and Patricia J. García
    Citation: Cost Effectiveness and Resource Allocation 2015 13:16
  10. After implementation of the PREDICA annual chest X-ray (CXR) screening program in smokers in the general practice setting of Varese-Italy a significant reduction in lung cancer-specific mortality (18 %) was ob...

    Authors: Paolo Pertile, Albino Poli, Lorenzo Dominioni, Nicola Rotolo, Elisa Nardecchia, Massimo Castiglioni, Massimo Paolucci, William Mantovani and Andrea Imperatori
    Citation: Cost Effectiveness and Resource Allocation 2015 13:15
  11. This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for measles in Be...

    Authors: Landry Kaucley and Pierre Levy
    Citation: Cost Effectiveness and Resource Allocation 2015 13:14
  12. Tiotropium (TIO) is a well-established bronchodilator, LAMA (long-acting anticholinergic), for the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). Clinical evidence suggests ...

    Authors: Oskar Eklund, Faraz Afzal and Fredrik Borgström
    Citation: Cost Effectiveness and Resource Allocation 2015 13:13
  13. For end-users of diabetes models that include UKPDS 82 risk equations, an important question is how well these new equations perform. Consequently, the principal objective of this study was to validate the UKP...

    Authors: Philip McEwan, Thomas Ward, Hayley Bennett and Klas Bergenheim
    Citation: Cost Effectiveness and Resource Allocation 2015 13:12
  14. Certolizumab pegol, a PEGylated tumour necrosis factor (TNF)-inhibitor, improves the clinical signs and symptoms of rheumatoid arthritis (RA) when used in combination with methotrexate or as monotherapy. This ...

    Authors: Álvaro Hidalgo-Vega, Renata Villoro, Juan Antonio Blasco, Pablo Talavera, Belén Ferro and Oana Purcaru
    Citation: Cost Effectiveness and Resource Allocation 2015 13:11
  15. The aim of this study was to compare the cost-utility of the first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with e...

    Authors: Panagiotis Stafylas, Georgia Kourlaba, Magda Hatzikou, Dimitrios Georgiopoulos, Pantelis Sarafidis and Nikolaos Maniadakis
    Citation: Cost Effectiveness and Resource Allocation 2015 13:10
  16. Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder which can affect multiple organs of the body, requiring ongoing disease management and healthcare resource utilization. The economic impact o...

    Authors: Cindy Garris, Manan Shah and Eileen Farrelly
    Citation: Cost Effectiveness and Resource Allocation 2015 13:9
  17. Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the ma...

    Authors: George M Ruhago, Frida N Ngalesoni, Bjarne Robberstad and Ole F Norheim
    Citation: Cost Effectiveness and Resource Allocation 2015 13:7
  18. Pneumococcal diseases in children under five years are common and preventable. In Colombia there are two pneumococcal conjugate vaccines (PCV) that have proved clinical efficacy. The aim was to estimate the co...

    Authors: Jaime E Ordóñez and John Jairo Orozco
    Citation: Cost Effectiveness and Resource Allocation 2015 13:6
  19. In 2004, the largest HIV prevention project (Avahan) conducted globally was implemented in India. Avahan was implemented by NGOs supported by state lead partners in order to provide HIV prevention services to ...

    Authors: Aurélia Lépine, Anna Vassall and Sudhashree Chandrashekar
    Citation: Cost Effectiveness and Resource Allocation 2015 13:5
  20. The purpose of this study was to assess the consequences of a national immunization program with HPV vaccine for both boys and girls in Denmark, including the prophylactic effects on all potentially vaccine pr...

    Authors: Jens Olsen and Tine Rikke Jørgensen
    Citation: Cost Effectiveness and Resource Allocation 2015 13:4
  21. This paper examines the cost-effectiveness of achieving increases in the use of oral rehydration solution and zinc supplementation in the management of acute diarrhea in children under 5 years through social f...

    Authors: David Bishai, Karampreet Sachathep, Amnesty LeFevre, Hnin New Nwe Thant, Min Zaw, Tin Aung, Willi McFarland and Dominic Montagu
    Citation: Cost Effectiveness and Resource Allocation 2015 13:3
  22. Efficient and evidence-based medical device and equipment prioritization is of particular importance in low-income countries due to constraints in financing capacity, physical infrastructure and human resource...

    Authors: Richard J Lilford, Samantha L Burn, Karin D Diaconu, Peter Lilford, Peter J Chilton, Victoria Bion, Carole Cummins and Semira Manaseki-Holland
    Citation: Cost Effectiveness and Resource Allocation 2015 13:2
  23. Understanding the cost-effectiveness and affordability of interventions to reduce maternal and newborn deaths is critical to persuading policymakers and donors to implement at scale. The effectiveness of commu...

    Authors: Tim Colbourn, Anni-Maria Pulkki-Brännström, Bejoy Nambiar, Sungwook Kim, Austin Bondo, Lumbani Banda, Charles Makwenda, Neha Batura, Hassan Haghparast-Bidgoli, Rachael Hunter, Anthony Costello, Gianluca Baio and Jolene Skordis-Worrall
    Citation: Cost Effectiveness and Resource Allocation 2015 13:1
  24. Harm reduction strategies commonly include needle and syringe programmes (NSP), opioid substitution therapy (OST) and interventions combining these two strategies. Despite the proven effectiveness of harm-redu...

    Authors: Sung Wook Kim, Anni-Maria Pulkki-Brannstrom and Jolene Skordis-Worrall
    Citation: Cost Effectiveness and Resource Allocation 2014 12:25
  25. The question of how to value lost productivity in economic evaluations has been subject of debate in the past twenty years. According to the Washington panel, lost productivity influences health-related qualit...

    Authors: Saskia Knies, Annelies Boonen and Johan L Severens
    Citation: Cost Effectiveness and Resource Allocation 2014 12:24
  26. Research priority setting aims to gain consensus about areas where research effort will have wide benefits to society. While general principles for setting health research priorities have been suggested, there...

    Authors: Jamie Bryant, Rob Sanson-Fisher, Justin Walsh and Jessica Stewart
    Citation: Cost Effectiveness and Resource Allocation 2014 12:23
  27. There is an increased interest in the use of multi-criteria decision analysis (MCDA) to support regulatory and reimbursement decision making. The EVIDEM framework was developed to provide pragmatic multi-crite...

    Authors: Janine van Til, Catharina Groothuis-Oudshoorn, Marijke Lieferink, James Dolan and Mireille Goetghebeur
    Citation: Cost Effectiveness and Resource Allocation 2014 12:22
  28. In Benin, malaria was the leading cause of hospital consultation for children less than 5 years old (47.2%), and for all patients not hospitalized (42.3%). Its incidence among those who attended a health facil...

    Authors: Charles Patrick Makoutodé, Martine Audibert and Achille Massougbodji
    Citation: Cost Effectiveness and Resource Allocation 2014 12:21
  29. Tuberculosis remains the leading cause of death in South Africa. A number of potential new TB vaccine candidates have been identified and are currently in clinical trials. One such candidate is MVA85A. This st...

    Authors: Liezl Channing and Edina Sinanovic
    Citation: Cost Effectiveness and Resource Allocation 2014 12:20
  30. Iron-deficiency anemia (IDA) is prevalent in patients with advanced chronic heart failure (CHF). It affects the patients’ overall physical condition and is suggested as a strong outcome predictor in CHF. Recen...

    Authors: Eun-A Lim, Hyun-Soon Sohn, Haeyoung Lee and Sang-Eun Choi
    Citation: Cost Effectiveness and Resource Allocation 2014 12:19
  31. This Guidance for Priority Setting in Health Care (GPS-Health), initiated by the World Health Organization, offers a comprehensive map of equity criteria that are relevant to health care priority setting and s...

    Authors: Ole F Norheim, Rob Baltussen, Mira Johri, Dan Chisholm, Erik Nord, DanW Brock, Per Carlsson, Richard Cookson, Norman Daniels, Marion Danis, Marc Fleurbaey, Kjell A Johansson, Lydia Kapiriri, Peter Littlejohns, Thomas Mbeeli, Krishna D Rao…
    Citation: Cost Effectiveness and Resource Allocation 2014 12:18
  32. The aim of the study was to investigate the changes in costs and outcomes after the implementation of various disease management programs (DMPs), to identify their potential determinants, and to compare the co...

    Authors: Apostolos Tsiachristas, Jane Murray Cramm, Anna P Nieboer and Maureen PMH Rutten-van Mölken
    Citation: Cost Effectiveness and Resource Allocation 2014 12:17
  33. To aid informed health sector decision-making, data from sufficient high quality economic evaluations must be available to policy makers. To date, no known study has analysed the quantity and quality of availa...

    Authors: Hassan Haghparast-Bidgoli, Aliasghar Ahmad Kiadaliri and Jolene Skordis-Worrall
    Citation: Cost Effectiveness and Resource Allocation 2014 12:15
  34. High maternal and infant mortality continue to be major challenges to the attainment of the Millennium Development Goals for many low and middle-income countries. There is now evidence that voucher initiatives...

    Authors: Chrispus Mayora, Elizabeth Ekirapa-Kiracho, David Bishai, David H Peters, Olico Okui and Sebastian Olikira Baine
    Citation: Cost Effectiveness and Resource Allocation 2014 12:14
  35. The objective of this study was to develop a rating tool for policy makers to prioritize breast cancer interventions in low- and middle- income countries (LMICs), based on a simple multi-criteria decision anal...

    Authors: Kristie Venhorst, Sten G Zelle, Noor Tromp and Jeremy A Lauer
    Citation: Cost Effectiveness and Resource Allocation 2014 12:13
  36. The continuing increase of pharmaceutical expenditure calls for new approaches to pricing and reimbursement of pharmaceuticals. Value based pricing of pharmaceuticals is emerging as a useful tool and possess t...

    Authors: Panagiotis Petrou and Michael A Talias
    Citation: Cost Effectiveness and Resource Allocation 2014 12:12
  37. There is little evidence to date of the potential impact of vegetable gardens on people living with HIV (PLHIV), who often suffer from social and economic losses due to the disease. From 2008 through 2011, Act...

    Authors: Chloe Puett, Cécile Salpéteur, Elisabeth Lacroix, Simbarashe Dennis Zimunya, Anne-Dominique Israël and Myriam Aït-Aïssa
    Citation: Cost Effectiveness and Resource Allocation 2014 12:11
  38. Low body mass index (BMI) individuals starting antiretroviral therapy (ART) for HIV infection in sub-Saharan Africa have high rates of death and loss to follow-up in the first 6 months of treatment. Nutritiona...

    Authors: John R Koethe, Elliot Marseille, Mark J Giganti, Benjamin H Chi, Douglas Heimburger and Jeffrey S Stringer
    Citation: Cost Effectiveness and Resource Allocation 2014 12:10
  39. In order to measure and analyse the technical efficiency of district hospitals in Ghana, the specific objectives of this study were to (a) estimate the relative technical and scale efficiency of government, mi...

    Authors: Caroline Jehu-Appiah, Serufusa Sekidde, Martin Adjuik, James Akazili, Selassi D Almeida, Frank Nyonator, Rob Baltussen, Eyob Zere Asbu and Joses Muthuri Kirigia
    Citation: Cost Effectiveness and Resource Allocation 2014 12:9
  40. To evaluate the impact of using network meta-analysis (NMA) versus pair wise meta-analyses (PMA) for evidence synthesis on key outputs of cost-effectiveness analysis (CEA).

    Authors: Kristian Thorlund, Zafar Zafari, Eric Druyts, Edward J Mills and Mohsen Sadatsafavi
    Citation: Cost Effectiveness and Resource Allocation 2014 12:8
  41. Complex clinical interventions are increasingly subject to evaluation by randomised trial linked to economic evaluation. However evaluations of policy initiatives tend to eschew experimental designs in favour ...

    Authors: David Cohen, M Fasihul Alam, Nishma Patel, Wai-Yee Cheung, John G Williams and Ian T Russell
    Citation: Cost Effectiveness and Resource Allocation 2014 12:7
  42. To estimate the cost-effectiveness of cataract surgery and refractive error/presbyopia correction in Zambia.

    Authors: Ulla K Griffiths, Fiammetta M Bozzani, Adrian Gheorghe, Lawrence Mwenge and Clare Gilbert
    Citation: Cost Effectiveness and Resource Allocation 2014 12:6
  43. To undertake an economic evaluation of rivaroxaban relative to the standard of care for stroke prevention in patients with non-valvular atrial fibrillation (AF) in Greece.

    Authors: Georgia Kourlaba, Nikos Maniadakis, George Andrikopoulos and Panos Vardas
    Citation: Cost Effectiveness and Resource Allocation 2014 12:5
  44. A healthy diet is associated with reduced risk of diabetes, cardiovascular disease and cancer. The study aimed to evaluate the cost-effectiveness of a universal strategy to promote healthy diet through brief i...

    Authors: Martin C Gulliford, Nawaraj Bhattarai, Judith Charlton and Caroline Rudisill
    Citation: Cost Effectiveness and Resource Allocation 2014 12:4
  45. Increasing the number of vaccine doses may potentially improve overall efficacy. Decision-makers need information about choosing the most efficient dose schedule to maximise the total health gain of a populati...

    Authors: Baudouin A Standaert, Desmond Curran and Maarten J Postma
    Citation: Cost Effectiveness and Resource Allocation 2014 12:3
  46. Multiple principles are relevant in priority setting, two of which are often considered particularly important. According to the greater benefit principle, resources should be directed toward the intervention ...

    Authors: Trygve Ottersen, Ottar Mæstad and Ole Frithjof Norheim
    Citation: Cost Effectiveness and Resource Allocation 2014 12:2

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.7
    5-year Journal Impact Factor: 2.1
    Source Normalized Impact per Paper (SNIP): 0.749
    SCImago Journal Rank (SJR): 0.610

    Speed 2023
    Submission to first editorial decision (median days): 6
    Submission to acceptance (median days): 157

    Usage 2023
    Downloads: 595,859
    Altmetric mentions: 2,584